Andrew Shepherd

Andrew Shepherd
Following completing his PhD Andrew has recently returned to full time clinical practice and is currently trying to acclimatise to life back within the NHS... He maintains his research interests and will take up a clinical lectureship post from February.

Website

Follow me here –

Psychotherapies for borderline personality disorder: DBT and psychodynamic approaches do best

jeffrey-wegrzyn-183859

Andrew Shepherd summarises a recent meta-analysis on the efficacy of psychotherapies for borderline personality disorder, which finds that dialectical behaviour therapy and psychodynamic approaches were effective versus control, but CBT and other talking treatments were not.

[read the full story...]

Time to stop prescribing antidepressants to young people with depression?

photo-1456397807017-5a6b47d257f4

Andrew Shepherd considers the implications of a recent network meta-analysis of the efficacy and tolerability of antidepressants for children and adolescents with depression.

[read the full story...]

What is the evidence for evidence-based guidelines?

photo-1444427169197-de497742b62d

Andrew Shepherd returns to the woodland with a blog about the evidence-practice gap in specialist mental healthcare; highlighting a recent systematic review and meta-analysis of guideline implementation studies.

[read the full story...]

Staff understanding of recovery-orientated mental health practice: A critical note of caution?

plants_hires

Andrew Shepherd considers the findings of a recent systematic review and narrative synthesis, which looks at staff understanding of recovery-orientated mental health practice.

[read the full story...]

Treatments for delusional disorder

shutterstock_274492739

Andrew Shepherd summarises a Cochrane systematic review of treatments for delusional disorder, which finds only 1 small RCT looking at treating the condition with medication or psychotherapy compared to placebo.

[read the full story...]

Quetiapine for schizophrenia: more transparency needed in clinical trial reporting

shutterstock_122223547

Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.

[read the full story...]

Dose equivalents of antidepressants: standardising prescribing between different drugs

shutterstock_125648294

Andrew Shepherd summarises a meta-analysis, which looks at the dose equivalents of antidepressants by bringing together data from 83 trials of 23 different antidepressants.

[read the full story...]

Personality disorder: time for more attention and debate

shutterstock_100999102

Andrew Shepherd summarises a recent series of papers in The Lancet which look at the latest research on personality disorders. This includes evidence on classification, prevalence, diagnosis, treatment and the experience of personality disorder across the life course.

[read the full story...]

Antidepressant withdrawal syndromes: time to grasp the nettle?

shutterstock_159290282

Andrew Shepherd appraises and summarises a systematic review of antidepressant withdrawal symptoms after SSRI discontinuation, which leads him to reconsider his own clinical practice.

[read the full story...]

Psychotherapy for depression in primary care. Better evidence please…

shutterstock_255750295

Andrew Shepherd summarises a recent systematic review of the effectiveness of psychotherapy for depression in primary care, which contains a lot of data but leaves him feeling rather deflated.

[read the full story...]